Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation
Pacing and Clinical Electrophysiology · 2024
DOI: 10.1111/pace.15051 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, 2024. Written by Raheel Ahmed and 17 co-authors. Institution: Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK. Major MEDLINE topics: Defibrillators, Implantable, Sarcoidosis. Cited 7 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Introduction
In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation.
Methods
The 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs.
Results
Among 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p < .01), had higher rates of diabetes (31.7% vs. 21.6%, p < .01) and chronic kidney disease (CKD) (16.8% vs. 7.8%, p < .01) but lower prevalence of atrial fibrillation (AF) (11.9% vs. 23.5%, p < .01), sick sinus syndrome (4.0% vs. 7.8%, p = .024), ventricular fibrillation (VF) (9.9% vs. 15.7%, p = .02), and black ancestry (31.9% vs. 58.0%, p < .01). Unadjusted major adverse cardiovascular events (MACE), defined as a composite of in‐hospital death, myocardial infarction (MI), and ischemic stroke, was higher in females (11.8% vs. 6.9%, p = .024), but when adjusted for age and tCharlson Comorbidity Index (CCI), females demonstrated significantly lower odds of experiencing MACE (aOR: 0.048, 95% CI: 0.006–0.395, p = .005). Incidence of acute kidney injury (AKI) post‐ICD was significantly lower in females (15.7% vs. 23.8%, p = .01) as was the adjusted odds (aOR: 0.282, 95% CI: 0.146–0.546, p < .01). There was comparable mean length of stay and hospital charges.
Conclusion
ICD utilization in CS patients is more common among males, who have a higher prevalence of diabetes and CKD but a lower prevalence of AF, sick sinus syndrome, and VF. Adjusted MACE and AKI were significantly lower in females.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK.
- National Heart and Lung Institute, Imperial College London, London, UK.
- Dow University of Health Sciences, Karachi, Pakistan.
- Independent Researcher, Triolet, Mauritius.
- Northumbria Hospitals, NHS Foundation Trust, Newcastle upon Tyne, UK.
- Abington Hosp- Jefferson Health, Horsham, USA.
ORCID profiles: Raheel Ahmed
Cite
APA
Ahmed, R., Jamil, Y., Ramphul, K., Mactaggart, S., Bilal, M., Singh Dulay, M., Shi, R., Azzu, A., Okafor, J., Memon, R. A., Sakthivel, H., Khattar, R., Wells, A. U., Baksi, J. A., Wechalekar, K., Kouranos, V., Chahal, A., & Sharma, R. (2024). Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.15051
Vancouver
Ahmed R, Jamil Y, Ramphul K, Mactaggart S, Bilal M, Singh Dulay M, et al. Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation. Pacing and Clinical Electrophysiology. 2024. doi:10.1111/pace.15051
BibTeX
@article{Ahmed2024,
author = {Ahmed, Raheel and Jamil, Yumna and Ramphul, Kamleshun and Mactaggart, Sebastian and Bilal, Maham and Singh Dulay, Mansimran and Shi, Rui and Azzu, Alessia and Okafor, Joseph and Memon, Rahat A and Sakthivel, Hemamalini and Khattar, Rajdeep and Wells, Athol Umfrey and Baksi, John Arun and Wechalekar, Kshama and Kouranos, Vasilis and Chahal, Anwar and Sharma, Rakesh},
title = {Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
doi = {10.1111/pace.15051}
}
EUVIMED